Global High Throughput Screening Market Size, Share, Forecast Report, 2020-2027
The global high throughput screening market is expected to register ~7.5% CAGR during the forecast period of 2019 to 2025, with a market value of USD 13,460 million in 2018.
High-throughput screening (HTS) is a method for scientific experimentation that is used in drug discovery and relevant to the fields of biology and chemistry. Using robotics, data processing/control software, liquid handling devices, and sensitive detectors, high-throughput screening allows a researcher to quickly conduct millions of chemical, genetic, or pharmacological tests. Through this process, one can rapidly identify active compounds, antibodies, or genes that modulate a biomolecular pathway. The results of these experiments provide starting points for drug design and for understanding the noninteraction or role of a particular location.
Segmentation
The global high throughput screening market has been segmented based on product & service, technology, applications, end user, and region.
The global market, based on product & service, has been bifurcated into reagents & assay kits, instruments, consumables & accessories, software, and services.
The reagents & assay kits segment is expected to hold a major share in the market due to large numbers of reagents and assay kits used in HTS techniques and increased government funding for life science research.
Based on technology, the global market is segmented into cell-based assays, 2D cell culture, 3D cell culture, 3D cell culture, perfusion cell culture, lab-on-a-chip (LOC), Ultra-high-throughput Screening, Bioinformatics, and Label-free Technology. The 3D cell culture segment is further bifurcated into scaffold-based technologies and scaffold-free technologies. The scaffold-based segment is further sub-segmented into hydrogels, inert matrix, and micropatterned surfaces, and the scaffold-free technologies segment is further segmented into microplate, hanging-drop plates, ultra-low binding plates, and other scaffold-free technologies.
Based on application, the global market is segmented into target identification & validation, primary and secondary screening, toxicology assessment, and others. The application segment is anticipated to be the fastest-growing due to increasing pharmaceutical R&D and increasing prevalence of several diseases.
Based on end user, the global market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations, and others.
Key Players
The key players operating in the global high throughput screening market are Aurora Biomed Inc. (Canada), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Hamilton (US), Axxam (Italy), Merck Group (Germany), Corning (US), BioTek (US), Beckman Coulter, Inc. (US), Agilent Technologies Inc. (US), Luminex Corporation (US), and Roche (Switzerland).
Global High Throughput Screening Market, by Product & Service
Global High Throughput Screening Market, by Technology
Global High Throughput Screening Market, by Applications
Global High Throughput Screening Market, by End User
Global High Throughput Screening Market, by Region
Europe
Asia-Pacific
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers